Vivity is the most implanted EDOF IOL globally.
'We are proud to celebrate the one million Vivity eyes empowering cataract patients to see the world with high quality vision from distance to functional near-day and night,' said
Vivity uses
Recent, large-scale real-world data underscores the impact of Vivity on patients across the globe. The Vivity Registry Study4+ includes patients with common mild comorbidities like glaucoma, dry eye and retinopathy/maculopathy, as well as post-refractive eyes. The Registry data demonstrates high patient satisfaction among several patient cohorts, as the vast majority of patients (92%) report they are satisfied with their sight. Additionally, more than 91% of patients report no haloes, glares, or starbursts.(+)
Vivity is available in more than 80 countries, including
About Vivity
The non-diffractive Clareon Vivity Extended Vision Hydrophobic Posterior Chamber IOLs (referred to as Clareon Vivity) and AcrySof IQ Vivity Extended Vision Posterior Chamber Intraocular Lens Model DFT015 (referred to as AcrySof IQ Vivity IOL) are UV-absorbing and blue-light-filtering foldable intraocular lenses (IOLs). Vivity IOL provides an extended range of vision from distance to near, with low levels of visual disturbances.
Potential side effects: As with any surgery, there is an implicit risk, whether or not the IOL is implanted. The complications of the IOL implantation surgery ranges from minor side effects (usually temporary) to serious complications. Patients with previous illnesses or disorders (such as chronic infections of the eye or eyelids, or diabetes) may present a higher risk of complications. Temporary surgical complications include, but are not limited to, reactions to medications such as irritation or mild allergic response, bleeding, redness, itching of the eye, sensitivity to light, swelling, corneal edema (swelling of the cornea), problems with the iris, cell growth in the IOL, and an increase temporary eye pressure. There is a small risk of needing further surgical treatment after the implantation of the initial IOL.
About PanOptix
The AcrySof IQ PanOptix Trifocal IOL and the Clareon PanOptix Trifocal IOL are types of multifocal IOLs used to focus images clearly onto the back of your eye (retina) to allow clear vision after the cataract removal. In addition, the center of the PanOptix Trifocal IOL allows for better near (reading) vision and intermediate (computer work) vision versus what a monofocal lens would provide.
Potential side effects: Due to the design of multifocal IOLs, there are some side effects that can be associated with the AcrySof IQ and Clareon PanOptix Trifocal IOL models. These may be worse than with a monofocal IOL, including visual disturbances, such as glare, rings around lights, starbursts (rays around light sources), and reduced contrast sensitivity (decrease in ability to distinguish objects from their background, especially in dim lighting). These side effects may make it more difficult to see while driving at night or completing tasks in low lighting conditions such as at night or in fog or in a dimly lit room after surgery as compared to before surgery.
Further, a toric IOL corrects astigmatism only when it is placed in the correct position in the eye. There is a possibility that the toric IOL could be placed incorrectly or could move within the eye. If the toric lens is not positioned correctly following surgery, the change in your astigmatism correction by the IOL, along with any necessary correction with glasses, may cause visual distortions. If the lens rotates in your eye, you may need additional surgery to reposition or replace the IOL.
About
Contact:
Tel: +41 589 112 111
Email: globalmedia.relations@alcon.com
(C) 2024 Electronic News Publishing, source